the CGM question that gets asked weekly, answered properly
hypoglycaemia. That is the whole post, but I will justify it. Everything else people worry about in c/glp1science is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort hypoglycaemia out first, and almost nobody does. I say this having got it wrong for 6…
Retitled to remove editorialising. Put the evidence in the body.
Has anyone actually got this in writing, or is it forum lore at this point?
Strongly agree. A1c matters as much as weight.
hypoglycaemia risk when stacked with A1c
insulin and sulfonylurea interactions are real hypo risk